Alpa Laboratories Faces Evaluation Adjustment Amid Mixed Financial Performance Indicators
Alpa Laboratories, a microcap in the Pharmaceuticals & Drugs sector, has experienced an evaluation adjustment due to shifts in its technical indicators. While the company maintains a low Debt to Equity ratio and shows strong long-term growth, recent bearish trends in technical metrics have influenced this change.
Alpa Laboratories, a microcap company in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation adjustment that reflects changes in its technical indicators. The stock's technical trend has shifted, indicating a more cautious outlook based on various metrics. Key financial metrics reveal that Alpa Laboratories has maintained a low Debt to Equity ratio, suggesting a conservative approach to leveraging. The company has also demonstrated healthy long-term growth, with operating profit increasing at an annual rate of 43.59%. Despite these positive aspects, the stock's technical indicators, including MACD and Bollinger Bands, have shown bearish tendencies, which have contributed to the recent revision in its evaluation.
In terms of profitability, Alpa Laboratories has reported a Return on Equity (ROE) of 9.38%, which indicates a modest level of profitability relative to shareholders' funds. The company has also achieved significant milestones in its quarterly performance, including a highest PAT of Rs 8.90 crore and an EPS of Rs 4.23.
Overall, the evaluation adjustment reflects a complex interplay of financial performance and technical trends for Alpa Laboratories.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
